DALS

NASDAQ

DA32 Life Science Tech Acquisition Corp.

SectorFinanceIndustryBlank ChecksIPO2021

$10.29+0.02 (+0.19%)

News25/Ratings0

DA32 Life Science Tech Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

Latest news

25 items

806d13D/G
SEC Form SC 13G/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)
SC 13G/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
955d13D/G
SEC Form SC 13G/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)
SC 13G/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
987dINSIDER
SEC Form 4: Crandell Keith disposed of 1,600,000 shares
4 - DA32 Life Science Tech Acquisition Corp. (0001863294) (Issuer)
987dINSIDER
SEC Form 4: Arch Venture Fund Xi, L.P. disposed of 1,600,000 shares
4 - DA32 Life Science Tech Acquisition Corp. (0001863294) (Issuer)
989d13D/G
SEC Form SC 13G/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)
SC 13G/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
990dSEC
SEC Form 15-12G filed by DA32 Life Science Tech Acquisition Corp.
15-12G - DA32 Life Science Tech Acquisition Corp. (0001863294) (Filer)
993d13D/G
SEC Form SC 13D/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)
SC 13D/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
995d13D/G
SEC Form SC 13D/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)
SC 13D/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
996dINSIDER
SEC Form 4: Deerfield Management Company, L.P. (Series C) disposed of 1,600,000 shares
4 - DA32 Life Science Tech Acquisition Corp. (0001863294) (Issuer)
996d13D/G
SEC Form SC 13D/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)
SC 13D/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
996d13D/G
SEC Form SC 13D/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)
SC 13D/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
1000dSEC
SEC Form 25-NSE filed by DA32 Life Science Tech Acquisition Corp.
25-NSE - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
1007dSEC
DA32 Life Science Tech Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - DA32 Life Science Tech Acquisition Corp. (0001863294) (Filer)
1007dNEWS
DA32 Life Science Tech Acquisition Corp. Announces Redemption Of Shares; Per-Share Redemption Price Of ~$10.31
DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS) today announced that its board of directors (the "Board") has determined to redeem all of its outstanding shares of Class A common stock (the "Public Shares"), effective as of July 28, 2023, because the Company will not consummate an initial business combination within the time period required by its amended and restated certificate of incorporation. As of the close of business on July 28, 2023, the Public Shares will be deemed cancelled and will represent only the rights to receive the per-share redemption price of approximately $10.31 (after taking into account the removal of a portion of the accrued interest in the trust account to p
1007dPR
DA32 Life Science Tech Acquisition Corp. Announces Redemption of Shares
DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS) today announced that its board of directors (the "Board") has determined to redeem all of its outstanding shares of Class A common stock (the "Public Shares"), effective as of July 28, 2023, because the Company will not consummate an initial business combination within the time period required by its amended and restated certificate of incorporation. As of the close of business on July 28, 2023, the Public Shares will be deemed cancelled and will represent only the rights to receive the per-share redemption price of approximately $10.31 (after taking into account the removal of a portion of the accrued interest in the trust account to
1074d13D/G
SEC Form SC 13G/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)
SC 13G/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
1077dSEC
SEC Form 10-Q filed by DA32 Life Science Tech Acquisition Corp.
10-Q - DA32 Life Science Tech Acquisition Corp. (0001863294) (Filer)
1109d13D/G
SEC Form SC 13G filed by DA32 Life Science Tech Acquisition Corp.
SC 13G - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
1121dSEC
SEC Form 10-K filed by DA32 Life Science Tech Acquisition Corp.
10-K - DA32 Life Science Tech Acquisition Corp. (0001863294) (Filer)
1164d13D/G
SEC Form SC 13G/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)
SC 13G/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
1172d13D/G
SEC Form SC 13G/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)
SC 13G/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
1172d13D/G
SEC Form SC 13G/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)
SC 13G/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
1178d13D/G
SEC Form SC 13G/A filed by DA32 Life Science Tech Acquisition Corp. (Amendment)
SC 13G/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
1260dSEC
SEC Form 10-Q filed by DA32 Life Science Tech Acquisition Corp.
10-Q - DA32 Life Science Tech Acquisition Corp. (0001863294) (Filer)
1347dSEC
SEC Form 10-Q filed by DA32 Life Science Tech Acquisition Corp.
10-Q - DA32 Life Science Tech Acquisition Corp. (0001863294) (Filer)